There's No Excuse For Doctors To Treat Patients According To Race
By Amitha Kalaichandran,
Huffington Post [Canada]
| 02. 16. 2016
Untitled Document
This past November I had the opportunity take part in TEDMED as a TEDMED Scholar. The week consisted of numerous talks from exceptional leaders in the field of health, medicine and innovation. There was also time set aside for discussion and debate. Few were as compelling as the presentation by Professor Dorothy Roberts.
Her poignant talk centered around how we view race in medicine. During her talk, which was just released, Professor Roberts suggests that we revisit the concept of race when it comes to delivering health care and conducting research on health.
I had a chance to ask Professor Roberts some follow-up questions around this very important topic as part of a three-part series interviewing engaging speakers from TEDMED -- speakers that aimed to push the envelope in their work, and innovate the world of health and medicine today and into the future.
AK: You gave an incredible TEDMED talk last month. Before we get into discussing some of the issues you described, do you mind sharing what inspired you to look deeper into understandings of...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...